LETKO BROSSEAU & ASSOCIATES INC 13D and 13G filings for Profound Medical Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-11 09:42 am Purchase |
2024-09-30 | 13G | Profound Medical Corp. PROF |
LETKO BROSSEAU & ASSOCIATES INC | 1,198,775 4.900% |
20,925 (+1.78%) |
Filing |
| 2024-02-12 2:37 pm Sale |
2023-12-31 | 13G | Profound Medical Corp. PROF |
LETKO BROSSEAU & ASSOCIATES INC | 1,177,850 5.500% |
-2,575 (-0.22%) |
Filing |
| 2023-02-09 5:42 pm Purchase |
2022-12-31 | 13G | Profound Medical Corp. PROF |
LETKO BROSSEAU & ASSOCIATES INC | 1,180,425 5.700% |
1,180,425 (New Position) |
Filing |